(Q73404323)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9178819%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

title

Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9178819%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9178819%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

author name string

F Y Yue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9178819%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

R Dummer

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9178819%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

R Geertsen

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9178819%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

E Laine

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9178819%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

S Manolio

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9178819%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

G Burg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9178819%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

language of work or name

English

0 references

publication date

1 May 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9178819%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Cancer

3 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9178819%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

volume

71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9178819%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9178819%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

page(s)

630-637

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9178819%20AND%20SRC:MED&resulttype=core&format=json

10.1002/(SICI)1097-0215(19970516)71:4<630::AID-IJC20>3.0.CO;2-E

3 November 2019

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9178819%20AND%20SRC:MED&resulttype=core&format=json

3 November 2019

1 reference